Pharmaceutical

Subscribe

The United States has passed a bill intended to set up a national system for tracking pharmaceutical products through the supply chain to prevent counterfeit medicines from accessing the market.

Big Chinese pharmaceutical companies are no longer happy playing only in their local markets. Several of them are hoping to establish a notable presence on the U.S. market, mostly through partnerships with international industry giants.

“I love all of it, to tell you the truth. Stainless just catches the eye,” said Craig Bell Jr., a representative with Alloy Products Corp. of Waukesha, Wis. That’s the kind of feeling for the utility and beauty of the materials sciences that was on location at Interphex, held in New York City’s Jacob Javits Center.

The U.S. FDA has warned in recent days that fraudulent versions of Allergan's drug Botox are being distributed here in the U.S. The agency called for healthcare practitioners and the general public to exercise caution when dealing with the drug.

Florida-based Balanced Solutions Compounding Pharmacy has issued a voluntary recall of all lots of its sterile non-expired drug products sold nationwide following concerns that their sterility may be compromised.

According to Thermo Fisher Scientific, the transaction "will create an unrivaled leader in serving research, speciality diagnostics and applied markets."

Drug manufacturer AstraZeneca has lost a legal battle in the United States after a court ruling that found its patent for a childhood asthma treatment invalid.

The 11 largest drug companies took $711.4 billion in profits over the 10 years ending in 2012, according to an analysis of corporate filings by Health Care for America Now (HCAN).

The Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food and Drug Administration (FDA) has recommended the approval of a new treatment for opioid addiction by Titan Pharmaceuticals, called Probuphine.